Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 219

1.

Association of dopamine, serotonin, and nicotinic gene polymorphisms with methylphenidate response in ADHD.

Tharoor H, Lobos EA, Todd RD, Reiersen AM.

Am J Med Genet B Neuropsychiatr Genet. 2008 Jun 5;147B(4):527-30.

PMID:
17948872
2.

A candidate gene analysis of methylphenidate response in attention-deficit/hyperactivity disorder.

McGough JJ, McCracken JT, Loo SK, Manganiello M, Leung MC, Tietjens JR, Trinh T, Baweja S, Suddath R, Smalley SL, Hellemann G, Sugar CA.

J Am Acad Child Adolesc Psychiatry. 2009 Dec;48(12):1155-64. doi: 10.1097/CHI.0b013e3181bc72e3.

3.

Catechol-O-methyltransferase Val158Met polymorphism is associated with methylphenidate response in ADHD children.

Kereszturi E, Tarnok Z, Bognar E, Lakatos K, Farkas L, Gadoros J, Sasvari-Szekely M, Nemoda Z.

Am J Med Genet B Neuropsychiatr Genet. 2008 Dec 5;147B(8):1431-5. doi: 10.1002/ajmg.b.30704.

PMID:
18214865
4.

Dopaminergic and noradrenergic gene polymorphisms and response to methylphenidate in korean children with attention-deficit/hyperactivity disorder: is there an interaction?

Hong SB, Kim JW, Cho SC, Shin MS, Kim BN, Yoo HJ.

J Child Adolesc Psychopharmacol. 2012 Oct;22(5):343-52. doi: 10.1089/cap.2011.0076.

PMID:
23083021
5.

No significant association between response to methylphenidate and genes of the dopaminergic and serotonergic systems in a sample of Brazilian children with attention-deficit/hyperactivity disorder.

Zeni CP, Guimarães AP, Polanczyk GV, Genro JP, Roman T, Hutz MH, Rohde LA.

Am J Med Genet B Neuropsychiatr Genet. 2007 Apr 5;144B(3):391-4.

PMID:
17171656
6.
7.

Attention-deficit hyperactivity disorder in adults: A systematic review and meta-analysis of genetic, pharmacogenetic and biochemical studies.

Bonvicini C, Faraone SV, Scassellati C.

Mol Psychiatry. 2016 Jul;21(7):872-84. doi: 10.1038/mp.2016.74. Epub 2016 May 24. Review.

8.

Genetic interaction analysis for DRD4 and DAT1 genes in a group of Mexican ADHD patients.

Gabriela ML, John DG, Magdalena BV, Ariadna GS, Francisco de LP, Liz SM, Lino PC, Josefina RG, Ernesto RZ, Carlos CF.

Neurosci Lett. 2009 Feb 27;451(3):257-60. doi: 10.1016/j.neulet.2009.01.004. Epub 2009 Jan 8.

PMID:
19146920
9.

High sibling correlation on methylphenidate response but no association with DAT1-10R homozygosity in Dutch sibpairs with ADHD.

van der Meulen EM, Bakker SC, Pauls DL, Oteman N, Kruitwagen CL, Pearson PL, Sinke RJ, Buitelaar JK.

J Child Psychol Psychiatry. 2005 Oct;46(10):1074-80.

PMID:
16178931
10.

Response to methylphenidate in adults with ADHD is associated with a polymorphism in SLC6A3 (DAT1).

Kooij JS, Boonstra AM, Vermeulen SH, Heister AG, Burger H, Buitelaar JK, Franke B.

Am J Med Genet B Neuropsychiatr Genet. 2008 Mar 5;147B(2):201-8.

PMID:
17955457
11.

Pharmacogenetic predictors of methylphenidate dose-response in attention-deficit/hyperactivity disorder.

Froehlich TE, Epstein JN, Nick TG, Melguizo Castro MS, Stein MA, Brinkman WB, Graham AJ, Langberg JM, Kahn RS.

J Am Acad Child Adolesc Psychiatry. 2011 Nov;50(11):1129-1139.e2. doi: 10.1016/j.jaac.2011.08.002. Epub 2011 Sep 15.

12.
14.

Effect of candidate gene polymorphisms on the course of attention deficit hyperactivity disorder.

Biederman J, Petty CR, Ten Haagen KS, Small J, Doyle AE, Spencer T, Mick E, Monuteaux MC, Smoller JW, Faraone SV.

Psychiatry Res. 2009 Dec 30;170(2-3):199-203. doi: 10.1016/j.psychres.2008.12.016. Epub 2009 Nov 10.

15.

Response to methylphenidate is not influenced by DAT1 polymorphisms in a sample of Brazilian adult patients with ADHD.

Contini V, Victor MM, Marques FZ, Bertuzzi GP, Salgado CA, Silva KL, Sousa NO, Grevet EH, Belmonte-de-Abreu P, Bau CH.

J Neural Transm (Vienna). 2010 Feb;117(2):269-76. doi: 10.1007/s00702-009-0362-2. Epub 2010 Jan 5.

PMID:
20049490
16.

Absence of association with DAT1 polymorphism and response to methylphenidate in a sample of adults with ADHD.

Mick E, Biederman J, Spencer T, Faraone SV, Sklar P.

Am J Med Genet B Neuropsychiatr Genet. 2006 Dec 5;141B(8):890-4.

17.

Haplotype study of three polymorphisms at the dopamine transporter locus confirm linkage to attention-deficit/hyperactivity disorder.

Barr CL, Xu C, Kroft J, Feng Y, Wigg K, Zai G, Tannock R, Schachar R, Malone M, Roberts W, Nöthen MM, Grünhage F, Vandenbergh DJ, Uhl G, Sunohara G, King N, Kennedy JL.

Biol Psychiatry. 2001 Feb 15;49(4):333-9.

PMID:
11239904
18.

An association between a dopamine transporter gene (SLC6A3) haplotype and ADHD symptom measures in nonclinical adults.

Tong JH, Cummins TD, Johnson BP, McKinley LA, Pickering HE, Fanning P, Stefanac NR, Newman DP, Hawi Z, Bellgrove MA.

Am J Med Genet B Neuropsychiatr Genet. 2015 Mar;168B(2):89-96. doi: 10.1002/ajmg.b.32283. Epub 2015 Feb 5.

PMID:
25656223
19.

Effects of source of DNA on genotyping success rates and allele percentages in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).

Swanson JM, Moyzis RK, McGough JJ, McCracken JT, Riddle MA, Kollins SH, Greenhill LL, Abikoff HB, Wigal T, Wigal SB, Posner K, Skrobala AM, Davies M, Ghuman JK, Cunningham C, Vitiello B, Stehli A, Smalley SL, Grady D.

J Child Adolesc Psychopharmacol. 2007 Oct;17(5):635-46.

PMID:
17979583
20.

Meta-analysis of the association between dopamine transporter genotype and response to methylphenidate treatment in ADHD.

Kambeitz J, Romanos M, Ettinger U.

Pharmacogenomics J. 2014 Feb;14(1):77-84. doi: 10.1038/tpj.2013.9. Epub 2013 Apr 16.

PMID:
23588108

Supplemental Content

Support Center